학술논문
Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis
Document Type
Article
Author
Wang, V.E.; Jiang, T.; Logan, A.C.; Mannis, G.N.; Olin, R.; Damon, L.E.; Martin, T.G.; Sayre, P.H.; Gaensler, K.M.; McMahon, E.; Flanders, M.; Weinberg, V.; Ye, C.J.; Munster, P.N.; Andreadis, C.; McCormick, F.; Blaser, B.W.; Behbehani, G.K.; Carbone, D.P.; Patel, R.K.; Rao, A.A.; Fragiadakis, G.K.; Durbin-Johnson, B.; Settles, M.
Source
In: Blood Cancer Discovery . (Blood Cancer Discovery, 1 September 2021, 2(5):434-449)
Subject
Language
English
ISSN
26433249
26433230
26433230